Cohort Studyhigh evidence
Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial.
BMJ (Clinical research ed.)·November 27, 2024·PMID 39603704
Why it mattersIt provides contemporary, large-scale evidence on cardiovascular safety differences by MHT formulation and route, helping clinicians tailor therapy to minimize cardiovascular risk in menopausal women.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled